Bellevue Asset Management, LLC Nevro Corp Transaction History

Bellevue Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$40.66 - $53.03 $935 - $1,219	23 New	23 $1,000
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $939 - $1,786	-23 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$59.95 - $92.06 $299 - $460	5 Added 27.78%	23 $2,000
Q4 2021 Feb 03, 2022	SELL	$81.07 - $121.29 $81 - $121	-1 Reduced 5.26%	18 $1,000
Q2 2021 Aug 09, 2021	SELL	$141.6 - $179.06 $283 - $358	-2 Reduced 9.52%	19 $3,000
Q1 2021 May 12, 2021	SELL	$132.81 - $182.18 $398 - $546	-3 Reduced 12.5%	21 $3,000
Q4 2020 Feb 11, 2021	SELL	$138.17 - $184.34 $1,105 - $1,474	-8 Reduced 25.0%	24 $4,000
Q3 2020 Nov 12, 2020	SELL	$114.09 - $145.51 $684 - $873	-6 Reduced 15.79%	32 $5,000
Q1 2020 May 13, 2020	BUY	$70.23 - $144.31 $1,264 - $2,597	18 Added 90.0%	38 $5,000
Q4 2019 Feb 13, 2020	BUY	$76.41 - $117.54 $1,528 - $2,350	20 New	20 $2,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.